Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Jul 20;18(7):e0288028. doi: 10.1371/journal.pone.0288028

Recruitment and retention interventions in surgical and wound care trials: A systematic review

Catherine Arundel 1,*, Andrew Mott 1
Editor: Elisa Ambrosi2
PMCID: PMC10358880  PMID: 37471398

Abstract

Background

Recruitment and retention to surgical trials has previously been reported to be problematic, resulting in research waste. Surgery often results in wounds, meaning these trials are likely to have similar populations. There is currently no systematic assessment of effective strategies for these populations and hence, systematic assessment of these was deemed to be of importance.

Methods

A systematic review was conducted. Studies were eligible if they were randomised controlled trials undertaken to test an intervention to improve recruitment or retention within a surgical or wound based host randomised controlled trial. MEDLINE, EMBASE, Cochrane Library, ORRCA Database and the Northern Ireland Hub for Trials Methodology Research SWAT Repository Store were searched. Two independent reviewers screened the search results and extracted data for eligible studies using a piloted extraction form. A narrative synthesis was used due to a lack of heterogeneity between strategies which prevented meta-analysis.

Results

A total of 2133 records were identified which resulted in 13 ultimately being included in the review; seven on recruitment and six on retention. All included studies were based within surgical host trials. Four of the seven recruitment studies focussed on the provision of consent information to participants, one focussed on study set up and one on staff training, with only one relating to consent information finding any significant effect. A range of retention strategies were assessed by the included studies, however only two found (pen vs no pen, mailing strategies) found any significant effect.

Conclusion

The included studies within a trial were all conducted within surgical trials. There was significant variation in strategies used, and limited replications and therefore further assessment may be warranted. Given the lack of studies embedded within wound care trials, further studies in this area are recommended.

Trial registration

PROSPERO (CRD42020205475).

Introduction

Fundamental to health research is the testing of interventions through randomised controlled trials (RCTs). The validity and reliability of RCTs is highly dependent on recruiting and retaining sufficient numbers of participants [1]. Reviews [25] have shown that RCTs have consistently struggled with recruitment and this continues to prevail with the most recent review demonstrating that only 63% of RCTs reviewed achieved the required sample size [2]. Approximately a quarter of trials also experience attrition resulting in greater than 10% of primary outcome data being unavailable for use in the end analysis [6]. Limited recruitment and retention can result in a number of issues, for example additional costs, the need for a study extension, reduced power and early termination of research activity, therefore resulting in significant research waste [1, 7].

Many methods to improve recruitment and retention are utilised by trialists, often with limited robust evidence to support their effectiveness. As a result, evidence-based methods to increase recruitment and retention to RCTs are becoming extremely necessary and valuable. The most robust way to assess recruitment and retention interventions is to embed or nest a randomised evaluation within a host trial, known as a study within a trial or SWAT [8]. Testing interventions in such a way ensures causality of intervention effectiveness is assessed [9].

The testing of recruitment and retention strategies has increased in recent years and strategies have been combined in Cochrane Reviews [10, 11]. Only a small number of interventions have provided strong evidence of their potential to affect recruitment [11] and there is currently no high certainty GRADE evidence for retention strategies [10]. In addition, in some instances evidence of effectiveness included in these reviews is derived from quasi, hypothetical, or non-randomised SWAT designs which may limit the applicability of effectiveness findings to a RCT design.

There is evidence that both the recruitment and retention rate of trials are strongly linked to the setting in which they are undertaken [3]. Although many strategies may be transferable across clinical populations and study settings, there may also be unique characteristics which make specific interventions more, or less, effective in certain settings. Despite this, the evidence for effectiveness of strategies for specific groups (clinical populations, research settings) remains limited.

Over 10 million surgical operations take place within the UK NHS on an annual basis [12] and approximately 2.2 million patients will have a chronic wound at any one time [13]. As a result, a significant number of surgery or wound care research studies will be ongoing at any one time.

It has been identified that one in five surgical trials are discontinued due to lack of recruitment, which is a huge source of research waste [14]. Reasons for this include clinician and patient treatment preferences, overestimation of the eligible patient pool and clinician time constraints (Crocker et al. [15]). Similarly, retention in surgical trials has also previously been reported to be problematic, particularly due to patient dissatisfaction in not receiving their preferred treatment, when no treatment is required after the initial procedure, or where a long follow up period is used [16, 17].

Surgical procedures often lead to wounds and so trials of surgical or wound care are likely to share similar populations. These populations may differ from those in other forms of trial, due to the nature and trajectory of the associated interventions and follow up, and so may respond differently to strategies tested. To our knowledge, no systematic assessment has been made of the effectiveness of recruitment and retention strategies for these populations. Given the ongoing surgical and wound care trials at our UKCRC registered clinical trials unit, and the limited evidence for effective strategies in specific groups, it was viewed that assessment of effective strategies for this sector was of importance [18].

This review therefore sought to establish the evidence base for strategies to improve the recruitment and retention of patients to surgical and wound care clinical trials. The secondary aims of this review were to identify gaps in the evidence base for RCTs in these patient populations and to evaluate the cost effectiveness of different strategies (cost per patient recruited or retained) for any interventions shown to be effective.

Methods

Protocol

A protocol for this systematic review was prospectively registered on PROSPERO (CRD42020205475) on the 22nd October 2020.

Eligibility criteria

Studies were eligible for inclusion if they

  • Enrolled adult participants (≥18 years) into a surgical or wound care randomised controlled trial (commonly referred to as the host trial).

  • Used a randomised controlled trial to test an intervention to improve either recruitment or retention to the surgical or wound trial (commonly referred to as a Study within a Trial or SWAT)

Studies were not eligible if either the SWAT or host trial was hypothetical, quasi-randomised or non-randomised.

Information sources and search strategy

Using previously published search strategies for recruitment and retention strategies in other patient groups, a search strategy was designed to identify published randomised trials which focussed on improving recruitment and retention in surgical and wound care randomised trials.

The strategy included three core components: recruitment or retention; randomised controlled trials; surgery and wound. The only limitation applied was that the articles were published in English. A copy of the full search strategy is included as S1 File.

Electronic databases including MEDLINE, EMBASE, Cochrane Library, ORRCA Database and the Northern Ireland Hub for Trials Methodology Research SWAT Repository Store were searched from date of inception to the date of the search on 26th January 2021. A further search to MEDLINE and EMBASE was undertaken on 7th February 2022 to identify any publications since the initial search.

In addition, article reference lists and bibliographic searches were undertaken during the screening process. The PROMETHEUS programme [19, 20] (hosted by York Trials Unit, University of York) was also contacted to obtain an update on the progress of any relevant SWATs.

Selection process

Titles and abstracts retrieved from the searches were downloaded into Rayyan (https://www.rayyan.ai/) and de-duplicated. The remaining titles and abstracts were independently screened by two reviewers (CA and AM) against the pre-specified inclusion and exclusion criteria. Full text copies were obtained for those articles deemed to be meeting inclusion criteria and these were again independently reviewed by two reviewers (CA and AM). Where necessary, documentation relating to the host trial (for example registry entry, protocols, published results) were obtained to aid eligibility assessment. In both instances, any disagreements were discussed and resolved.

Risk of bias assessment

The Cochrane Risk of Bias tool (version 2) was used to assess risk of bias [21], applying all domains of the tool. An assessment was made only of the SWAT outcomes and not of the host trials. Two reviewers independently assessed the risk of bias for each included outcome and any disagreements in assessment were resolved by discussion.

Confidence in cumulative evidence

The strength of the evidence was assessed using GRADE [22]. An assessment was made only of the SWATs and not of the host trials. One reviewer independently assessed GRADE for each included study and this assessment was reviewed and agreed with the second reviewer.

Data collection and items

Using a standardised data extraction form, data extraction was completed independently by two reviewers (CA and AM) and compared for consistency. The extraction form was piloted prior to full data extraction.

Outcome data

Outcome data were collected on the number of participants either recruited (i.e., consented and randomised) or retained (i.e., providing outcome data) within each SWAT at any time point.

Secondary outcomes collected included:

  • Cost-effectiveness: defined as cost per additional participant recruited or retained.

  • Additionally for retention SWATS the retention of participants at subsequent timepoints was assessed.

Data items

Data was collected regarding the characteristics of both the host trial and the SWAT. The following items were collected:

Host trial:

  • Clinical Specialty

  • Surgical or Wound Care trial

  • Setting (primary or secondary care)

  • Trial Design

  • Trial Interventions

  • Total required sample size

  • Primary Outcome Measure

  • Recruitment method (remote, in clinic, etc.)

  • Follow-up methods (remote, in clinic, etc.)

SWAT:

  • Trial Design

  • Participant characteristics

  • Intervention details

  • Comparator details

  • Number of participants or sites recruited to each arm

  • Primary outcome

  • Number of participants recruited or retained

  • Secondary Outcomes collected

  • Cost effectiveness

  • Number of participants recruited or retained at further timepoints

Synthesis

A study flowchart of the study selection process is presented. Key study characteristics are summarised in tables and trials will be grouped by type of intervention.

A narrative synthesis is presented for each intervention. Studies at high risk of bias will be included in the results however all results will be discussed within the context of the ROB assessment. Where available data of the cost effectiveness of an intervention will be presented if an intervention has been shown to be effective. No sub-group or sensitivity analyses were planned.

Data from studies with multiple publications were extracted and reported as a single study. Multiple recruitment or retention interventions tested within the same host trial were extracted and treated as separate studies.

Results

In total our searches identified 2189 records of which 70 were identified as duplicates. Of the 2119 screened, 25 were included for full-text review. Following full-text review, 12 records were eligible for inclusion [2334]. A further record was subsequently identified for inclusion on the basis that 62.5% of studies included in the record were surgical or wound care related [35]. This resulted in a total of 13 included records [2335].

A study flowchart is presented in Fig 1. Five additional studies were identified that were ongoing [3639].

Fig 1. PRISMA flow diagram of screening.

Fig 1

Study characteristics

Of the studies included seven tested interventions addressing recruitment and six tested interventions addressing retention. Additionally, five ongoing studies were identified. The studies were primarily surgical, with two being wound-based. The recruitment method for all studies was a direct approach (i.e., face to face recruitment). The retention method for the majority of SWATs addressing retention was postal questionnaire follow-up with two studies included by Coleman et al. [35], using a combination of postal and clinic follow up (Table 1).

Table 1. Study characteristics.

Author (year) Clinical Speciality Surgical/ Wound Host Recruitment method Host Follow-up Method Planned Sample Size (Host:SWAT) SWAT Intervention SWAT Control Outcomes Collected
Recruitment Abd-Elsayed et al. (2012) [23] Cardiology Surgical Direct approach NS NS:526 Enhanced consent documents Standard consent documents Proportion consenting to trial
Brubaker et al. (2019) [24] Obstetrics & Gynacology Surgical Direct approach Clinic Visit 374:340 Information video Standard consent Proportion consenting to trial
Proportion completing extended follow-up
Eccles et al. (2002) [32] Urology Surgical Direct approach NS 400:30 Decision Aid Video Standard consent process Proportion of participants randomised to trial
Donovan et al. (2003) [25] Urology Surgical Direct approach NS NS:150 Nurse Provided information Urologist provided information Number recruited to trial
Jefferson et al. (2018) [26] Orthopaedics Surgical Direct approach Postal or Clinic visit 438 In person Study Set up Remote Study set up Time to:
R&D approval
final site initiation visit
first randomised participant
number of participants screened
proportion of eligible participants randomised
Parker et al. (2022) [33] Multiple Specialities (SWAT covering four trials) Surgical Direct Approach Postal follow-up NA Study Site receives QuinteT Recruitment Intervention & GRANULE online training No Training 1)
Feasibility & acceptability of intervention.
2)
Participant screening and recruitment rate (defined as the proportion of eligible participants who gave their consent and were randomised into the host trial six months following delivery of the course).
Agni et al. (2022) [34] Orthopaedic Surgical Direct Approach Telephone or postal 4106:NS Enhanced Trainee Principal Investigator (TPI) package; Digital Nudge; TPI and Digital Nudge Usual Practice Proportion of participant randomised (in first 6months of recruitment)
Retention Watson A et al. (2017) [27] Gastroenterology Surgical Direct approach Postal Follow-up 800:600 Vouchers at one or two follow-up time points (12 & 24 month) No Voucher Response rate at each follow-up timepoint
Mitchell et al. (2020a) [29] Orthopaedics Surgical Direct approach Postal Follow-up 2600:2306 Inclusion of pen with follow-up No pen Response rate at follow-up
Mitchell et al. (2020b) [29] Orthopaedics Surgical Direct approach Postal Follow-up 2600:1470 Personalised SMS reminder of follow-up Standard SMS reminder of follow-up Response rate at follow-up
Sarathay et al. (2020) [30] Orthopaedics Surgical Direct approach Postal Follow-up 500:269 pre-notification SMS of questionnaire SMS after questionnaire posted Response rate to follow-up
Coleman et al. (2021) [35] Surgical: (Orthopaedic n = 2; Urology n = 1; Gastroenterology n = 1)
Wound care: Vascular n = 1
Surgical/Wound NS Postal Follow up or Postal/Clinical follow up NS Festive greetings card No festive greetings card Response rate at follow up
Renfroe et al. (2002) [31] Cardiology Surgical Direct approach Clinical Review & postal follow-up 1200:664 Express delivery of questionnaire Regular Mail Response rate to follow-up
Certificate of Appreciation No certificate
Early delivery (1–2 weeks) Later delivery (1–4 months)
Study coordinator signed letter PI signed letter
Unpublished / Ongoing Reed et al. [39] Orthopaedics Surgical Direct Approach Based on SWAT Ongoing Postal Follow-up Telephone Follow-up Response rate to follow-up
Starr et al. [36] Urology Surgical Direct approach Paper Questionnaires provided following intervention Ongoing Theoretically informed leaflet in the participant pack Generic compliments slip in the participant pack Response rate at follow-up
Arundel et al. [38] Vascular Wound Direct Approach Clinical review & postal follow-up Ongoing Sending of Thank You card between follow-ups Usual Follow-up Proportion of participants returning questionnaire at first postal follow-up.
McCaffery et al. [37] Vascular Wound Direct Approach Clinical review & postal follow-up Ongoing Infographic + Patient information leaflet Patient information leaflet alone Difference in site recruitment rate
Montgomery et al. [40] Oncology Surgical Direct approach Telephone or clinic visit Ongoing Pictorial aid at end of information sheet depicting randomisation and trial treatment arms Standard participant information sheet Proportion of participants randomised

NS: Not Specified; NA: Not Applicable.

Risk of bias

The outcomes of the 13 studies included in this review were assessed using the Cochrane Risk of Bias 2 tool, and results are summarised in Fig 2.

Fig 2. Risk of bias assessment of included RCTs.

Fig 2

Overall the included studies were reasonably well reported with eight studies with low risk of bias [26, 2830, 3234], four with some concerns with bias [23, 24, 27, 31] and one study assessed as being at high risk of bias [25]. Donovan et al. was considered high risk of bias due to limited reporting in relation to measurement of outcomes. The reasons for some concerns were largely due to limited reporting of the randomisation process or deviations from intended intervention.

GRADE assessment

Overall, certainty of evidence for the included studies, as assessed by GRADE, was deemed to be low. As detailed in S2 File, seven studies (64%) were deemed to have low GRADE assessment, three studies were deemed to have moderate GRADE evidence and two were deemed to have very low GRADE evidence. The main driver for the low GRADE evidence was associated risk of bias and/or imprecision arising due to wide confidence intervals or being a single study.

Analysis

Due to the lack of consistency in the interventions evaluated in the included studies it was inappropriate to undertake a meta-analysis and hence a narrative synthesis was conducted, grouped by recruitment and retention SWATs. A summary of the recruitment and retention outcomes is provided in Table 2.

Table 2. Summary of study results—Recruitment & retention outcomes.

Study Total Participants Control Group Total Control group Recruited Intervention Group Total Intervention Group Recruited
Abd Elsayed et al. (2012) 499 251 189 248 164
Brubaker et al. (2019) 305 152 143 153 142
Donovan et al. (2003) 150 75 53 75 50
Study Total Participants Control Group Total Control group Retained Intervention Group Total Intervention Group Retained
Eccles et al. (2002) 30 15 3 15 1
Jefferson et al. (2018) 37 sites 20 sites N/A 17 sites N/A
Parker et al. (2022) NR NR NR NR NR
Agni et al. (2022) 20 sites 6 sites 379 participants 5
4 sites
5
279
147 participants
410
Watson et al. (2017) 521 132 12M: 98
24M: 98
Voucher 12M 142 12M:98
24M:100
Voucher 24M 123 12M:90
24M:86
Voucher Both 124 12M:93
24M:92
Mitchell et al. (2020a) 2306 1147 982 1146 1020
Mitchell et al. (2020b) 1470 742 654 723 644
Renfroe et al. (2002)—Mail Type 644 322 219 322 242
Renfroe et al. (2002) -
Certificate
644 322 242 322 219
Renfroe et al. (2002)–
Timing
644 322 232 322 255
Renfroe et al. (2002) -
Letter signature
644 322 226 322 235
Sarathay et al. (2020) 269 134 119 135 122
Coleman et al. (2021) 1103 (3223 including non-surgical/wound) 547 289 553 293

NR: Not Reported; M: Months.

Recruitment

All seven recruitment SWATs identified were embedded within surgical host trials with a direct, face to face approach to participant recruitment. Only two SWATs [23, 24] reported participant demographic criteria, and in both instances the populations were older white caucasian adults (Abd-Elsayed: Age range 62 +/- 13 years, >90% caucasian; Brubaker: Age range 57, >80% white). The host trials included a range of conditions, with only two studies [25, 32] undertaken in the same area (Urology). All the included studies used individual randomisation across a range of surgical trials.

Four of the seven SWATs [2325, 32] focussed on the provision of consent information to participants, one SWAT [26] focussed on study set up and two on staff training [33, 34].

All of the SWATs which focussed on consent information (modification to the consent process [18] and modification to how information was presented [19, 20, 27] reported a higher proportion of recruitment in the control arm compared with the intervention arm although there was no statistically significant difference in two of the studies [24, 25]. Abd-Elsayed [23] however reported that enhanced consent materials significantly reduced (p = 0.03) the odds of consenting.

The study by Jefferson et al. [26], compared an onsite face to face initial meeting (plus standard site initiation visit) with a remote initial meeting (plus standard site initiation visit) and identified that those sites who received the intervention had a higher consent rate compared to the control sites (0.63 vs 0.53), although the mean number of participants recruited favoured the control group (10 vs 11).

The study by Parker et al. [33] assessed the effect of a recruiter training course on obstacles and challenges to recruitment, derived from a synthesis of the QUINTET Recruitment Intervention [41], and online GRANULE training [42] on recruitment. The study identified no difference in the number of participants screened (coefficient −0.35, 95% CI -7.84 to 7.15, p = 0.92) or recruited (coefficient -0.07, 95% CI -0.43 to 0.29, p = 0.66) between sites that received the intervention and those that did not. The study by Agni et al. [34], assessed the effect of enhanced training and support for Trainee Principal Investigators (TPI) and personalised digital nudging to recruiters on recruitment rates. There was a statistically significant benefit to recruitment (Incidence rate ratio 1.23, 95% CI 1.09 to 1.40, p = 0.001) from the enhanced TPI intervention, but no significant effects were seen from the digital nudge component.

Cost effectiveness of the interventions was assessed only in two studies [25, 26]. The onsite face to face meeting was more costly than the remote initial meeting (£1016.93 vs £727.10) [26] and consent provision was cheaper when provided by a nurse vs a urologist (Difference 6.89, 95% CI 0.3 to 13.4, p = 0.039) [25].

A further two recruitment SWATs [37, 40] were identified during the search but remained ongoing, with no data reported, at the time of analysis. One of the studies was being hosted in a wound care trial [37] and one in a surgical trial [40]. Both focused on provision of information for participant consent.

Retention

Of the six retention SWATs identified, the majority were embedded within surgical host trials with postal follow up. Renfroe et al. [31] also used clinical notes review as part of their follow up processes, and two of the included studies in Coleman et al. [35] used postal and clinical follow up, and included one wound care trial. The majority of the studies (n = 3, 60%) were hosted solely in orthopaedic surgical trials [2830] with Coleman et al. also including two orthopaedic trials. Three of the SWATs were factorial [27, 31, 34], with the remaining studies using individual randomisation.

Participant demographics were well reported for the retention SWATs, with each publication providing age and gender, although ethnicity was only reported in two SWATs [31, 35]. Similarly, to the recruitment SWATs, participants were older (Range 49–76 years) however with a relatively even split between male and female participants (average 50.96% male). Two of the six SWATs [2325, 32] focussed on the use of SMS (text messaging) with participants, with the remaining SWATs focussing on financial incentives [22], inclusion of pens [24], postal delivery methods [26] or festive greetings cards [35].

A range of retention interventions were assessed and none assessed the same intervention as any other, although Mitchell et al. [28] and Sarathay et al. [30] both used text messaging interventions (personalised reminder and prenotification respectively).

Only two SWATs identified statistically significant differences in retention. Mitchell et al. [29] found that including a pen with a postal questionnaire increased response rates by 3.4% (95% CI 0.7 to 6.1, p = 0.01) and Renfroe et al. [31] found that using overnight mail (p = 0.04), including a certificate of a appreciation (p = 0.05) and later delivery (p = 0.09) improved response rates.

One SWAT [35] conducted a meta-analysis and found no evidence of a difference in retention rates when a festive greetings card was used compared to when it was not (Odds ratio: 0.96, 95% CI 0.71 to 1.79, p = 0.77).

Intervention cost was only reported by one of the included studies [35], however cost effectiveness was not assessed due to primary outcome finding no evidence of additional retention. The impact of the intervention on retention at subsequent timepoints was not assessed by any of the included studies.

A further three retention SWATs [36, 38, 39] were identified during the search but remained ongoing, with no data reported, at the time of analysis. Two studies [36, 39] were hosted in a surgical trial, and focused on postal vs telephone follow up and inclusion of a theoretically informed questionnaire cover letter vs a generic letter respectively. The remaining study by Arundel et al. [38] was hosted in a wound care trial and focused again on a thank you card sent between follow up timepoints.

Discussion

This review identified 13 eligible randomised controlled studies within a trial of recruitment and retention interventions for surgical or wound care studies. Due to the heterogeneity between interventions, it was not possible to combine any studies in a meta-analysis.

The majority of recruitment studies focussed on consent provision, which correlates with the findings of the Cochrane review by Treweek et al. [11] where modification to consent processes or the methods by which information was presented were the most frequent SWATs. Only one study included in this review [23] relating to consent materials reported a statistically significant effect of the intervention that the enhanced consent materials used reduced the odds of consent. Only one other study found a statistically significant benefit to recruitment through inclusion of an enhanced TPI intervention [34]. Due to the heterogeneity of included recruitment interventions and the small sample sizes of the existing studies which limits the provision of reliable evidence and ascertainment of intervention effectiveness, additional replications are recommended to build this evidence base and to ascertain GRADE certainty evidence for interventions. None of the recruitment SWATs identified within this review were those identified as priorities by the Cochrane review of recruitment methods for RCTs [11]. Trialists should therefore also consider replication of these priority SWATs in surgical and wound care trials in order to help build the evidence base for these interventions.

The reporting of demographic data in recruitment SWATs identified was poor. Given that many under-served groups are often not represented in trials it should be a key aspect of reporting for recruitment SWATs to ensure that certain populations are not disadvantaged by a recruitment or retention strategy [43, 44]. This also limits the generalisability of these results as those that did report demographic data predominantly included older Caucasian participants.

The majority of the SWATs included in this review focussed on retention in relation to postal questionnaire response rates. This correlates with the recent Cochrane review by Gillies et al. [10]. Only two of the retention SWATs included in this review [29, 31] identified statistically significant differences in response rates when a pen was included [29] and overnight mail, a certificate of appreciation and later delivery [31] were used. One SWAT [35] found that there was no evidence of a difference in retention rates when a festive greetings card was used compared to when it was not (Odds ratio: 0.96, 95% CI 0.71 to 1.79, p = 0.77) and recommended festive greetings cards should not be used as a method of retention. While the associated meta-analysis includes three studies outside of the eligible patient group for this review, we suggest that this finding still holds for surgical and wound care populations.

As with the recruitment SWATs, additional replications are recommended due to the limited evidence available currently. Three of the retention SWATs [22, 24, 26] identified within this review corresponded to Priority A SWATs (low certainty evidence requiring rigorous replication) identified in the Cochrane review of retention methods for RCTs [10]. These SWATs will contribute to the building evidence base for these interventions however further replications are likely to still be necessary to ensure high certainty evidence of effectiveness is ascertained.

In this review, cost effectiveness of interventions was to be assessed, however this was only reported in two recruitment studies [25, 26] and costs were also reported in one retention study [35]. Findings were to be expected given the associated resource implications; additional visits to sites and recruitment by a urologist rather than a nurse were more expensive. Retention at subsequent time points was not assessed in any of the included retention SWATs. When considering the need for further replications of SWATs, recent guidance [18] indicates that consideration should be given the generalisability of the populations and host trial interventions already included in a meta-analysis of a SWAT intervention. This is an important point to consider in the context of research waste. For example with the inclusion of pens with a postal questionnaire to improve retention, there is only one SWAT in a surgical and wound care population, however there is an existing meta-analysis [45] of pen SWATs across populations which indicates a 1.9% increase in retention when a pen is included with a questionnaire for which there is moderate GRADE certainty overall and high GRADE certainty evidence for older populations. In light of this further replications may not be justified within surgical or wound care populations specifically.

Half of the studies included used clinic follow-up either alone or in conjunction with remote, postal follow-up. Improving attendance at face-to-face visits in trials was an evidence gap identified by the most recent systematic review of retention strategies across all studies [10]. Surgical and wound care trials may therefore be an ideal context in which to test further strategies aimed at enhancing face-to-face follow-up.

Limitations

Firstly, the majority of studies identified in this review were in relation to surgical rather than wound care trials which limits the applicability of the review to trials in this area looking for potential interventions to include. Two further wound care studies were identified however results were not yet available, and the authors are aware of further SWATs also being conducted in wound care studies [46]. As a result, the limited evidence base should continue to build here over time, however trialists undertaking wound care studies are encouraged to include a randomised SWAT to allow the evidence base for effective interventions to build in this area.

Secondly, limited information on cost effectiveness and impacts on further retention, was available and hence there remains significant uncertainty around potentially cost-effective interventions at this time.

We acknowledge a limitation of our search strategy in that only publications in the English language were included in the review, thus including potential language bias. Given that no SWATs were identified in the search which were written in languages other than English we view the impacts of this limitation to be limited.

Due to the diversity of specialties and conditions related to surgery and wound care, and the variants in the description of SWATs (e.g., nested, SWAT, study within a trial, embedded) it proved difficult to develop a precise search strategy. The strategy therefore opted for increased sensitivity rather than precision by using the overarching terms Surgery and Wound, along with relevant terms as used in the Cochrane reviews [10, 11] in relation to SWATs, to attempt to ensure all relevant studies were captured. We acknowledge that despite this approach, there is potential for some SWATs to have been missed, however we anticipate minimal impact from this due to the range of databases and resources searched.

Finally, we acknowledge potential inaccuracy in relation to the risk of bias assessment completed, due to the fact that the domains in the Risk of Bias 2 tool [21] do not necessarily fit easily with the SWAT design. Risk of Bias was assessed independently by the two authors to mitigate this as far as possible.

Conclusion

This review has identified the different interventions which have previously or are currently being tested to improve recruitment and retention in surgical and wound care trials. The included studies within a trial had significant variation in interventions used, and the predominance of SWATs conducted thus far in these two areas are within surgical trials. Further SWATs in wound care studies are therefore recommended. Further replications of SWATs previously undertaken in surgical trials are also recommended to ensure clear evidence and certainty of this in relation to interventions, subject to the need for further replications which should be assessed appropriately in line with existing Trial Forge Guidance for the avoidance of research waste [18].

Supporting information

S1 File

(DOCX)

S2 File

(DOCX)

Data Availability

Datasets and associated documentation used in this study will be available in the FigShare database https://figshare.com/ 10.6084/m9.figshare.23580270.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Ioannidis JPA. Why most discovered true associations are inflated. Epidemiology. 2008;19: 640–648. doi: 10.1097/EDE.0b013e31818131e7 [DOI] [PubMed] [Google Scholar]
  • 2.Jacques RM, Ahmed R, Harper J, Ranjan A, Saeed I, Simpson RM, et al. Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997–2020). BMJ Open. 2022;12: e059230. doi: 10.1136/bmjopen-2021-059230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Walters SJ, Bonacho Dos Anjos Henriques-Cadby I, Bortolami O, Flight L, Hind D, Jacques RM, et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open. 2017;7: e015276. doi: 10.1136/bmjopen-2016-015276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sully BGO, Julious SA, Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Trials. 2013;14: 166. doi: 10.1186/1745-6215-14-166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7: 9. doi: 10.1186/1745-6215-7-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hewitt CE, Kumaravel B, Dumville JC, Torgerson DJ. Assessing the impact of attrition in randomized controlled trials. Journal of Clinical Epidemiology. 2010. pp. 1264–1270. doi: 10.1016/j.jclinepi.2010.01.010 [DOI] [PubMed] [Google Scholar]
  • 7.Moher D, Glasziou P, Chalmers I, Nasser M, Bossuyt PMM, Korevaar DA, et al. Increasing value and reducing waste in biomedical research: who’s listening? Lancet. 2016;387: 1573–1586. doi: 10.1016/S0140-6736(15)00307-4 [DOI] [PubMed] [Google Scholar]
  • 8.Treweek S, Bevan S, Bower P, Campbell M, Christie J, Clarke M, et al. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? Trials. 2018;19: 139. doi: 10.1186/s13063-018-2535-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bowling Ann. Research Methods In Health: Investigating Health And Health Services. McGraw-Hill Education (UK); 2014. [Google Scholar]
  • 10.Gillies K, Kearney A, Keenan C, Treweek S, Hudson J, Brueton VC, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2021;3: MR000032. doi: 10.1002/14651858.MR000032.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Treweek S, Pitkethly M, Cook J, Fraser C, Mitchell E, Sullivan F, et al. Strategies to improve recruitment to randomised trials. Cochrane Database Syst Rev. 2018;2: MR000013. doi: 10.1002/14651858.MR000013.pub6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chetter IC, Oswald AV, Fletcher M, Dumville JC, Cullum NA. A survey of patients with surgical wounds healing by secondary intention; an assessment of prevalence, aetiology, duration and management. J Tissue Viability. 2017;26: 103–107. doi: 10.1016/j.jtv.2016.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, et al. Health economic burden that different wound types impose on the UK’s National Health Service. Int Wound J. 2017;14: 322–330. doi: 10.1111/iwj.12603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chapman SJ, Shelton B, Mahmood H, Fitzgerald JE, Harrison EM, Bhangu A. Discontinuation and non-publication of surgical randomised controlled trials: observational study. BMJ. 2014;349: g6870. doi: 10.1136/bmj.g6870 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Crocker JC, Farrar N, Cook JA, Treweek S, Woolfall K, Chant A, et al. Recruitment and retention of participants in UK surgical trials: survey of key issues reported by trial staff. BJS Open. 2020;4: 1238–1245. doi: 10.1002/bjs5.50345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Farrokhyar F, Karanicolas PJ, Thoma A, Simunovic M, Bhandari M, Devereaux PJ, et al. Randomized controlled trials of surgical interventions. Ann Surg. 2010;251: 409–416. doi: 10.1097/SLA.0b013e3181cf863d [DOI] [PubMed] [Google Scholar]
  • 17.Michaels JA, Brazier JE, Campbell WB, MacIntyre JB, Palfreyman SJ, Ratcliffe J. Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg. 2006;93: 175–181. doi: 10.1002/bjs.5264 [DOI] [PubMed] [Google Scholar]
  • 18.Treweek S, Bevan S, Bower P, Briel M, Campbell M, Christie J, et al. Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed. Trials. 2020;21: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Arundel CE, Clark LK, Coleman E, Doherty L, Parker A, Torgerson DJ. Challenges and Solutions to the Implementation of Studies Within A Trial (SWATs): The Experiences of the PROMETHEUS Programme. Research Methods in Medicine & Health Sciences. 2022. [cited 16 Aug 2022]. Available: https://eprints.whiterose.ac.uk/186830/ [Google Scholar]
  • 20.Clark L, Arundel C, Coleman E, Doherty L, Parker A, Hewitt C, et al. The PROMoting the USE of SWATs (PROMETHEUS) programme: Lessons learnt and future developments for SWATs. Research Methods in Medicine & Health Sciences. 2022; 26320843221089630. [Google Scholar]
  • 21.Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019. p. l4898. doi: 10.1136/bmj.l4898 [DOI] [PubMed] [Google Scholar]
  • 22.Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64: 383–394. doi: 10.1016/j.jclinepi.2010.04.026 [DOI] [PubMed] [Google Scholar]
  • 23.Abd-Elsayed AA, Sessler DI, Mendoza-Cuartas M, Dalton JE, Said T, Meinert J, et al. A randomized controlled study to assess patients’ understanding of and consenting for clinical trials using two different consent form presentations. Minerva Anestesiol. 2012;78: 564–573. [PubMed] [Google Scholar]
  • 24.Brubaker L, Jelovsek JE, Lukacz ES, Balgobin S, Ballard A, Weidner AC, et al. Recruitment and retention: A randomized controlled trial of video-enhanced versus standard consent processes within the E-OPTIMAL study. Clin Trials. 2019;16: 481–489. doi: 10.1177/1740774519865541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Donovan JL, Peters TJ, Noble S, Powell P, Gillatt D, Oliver SE, et al. Who can best recruit to randomized trials?: Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol. 2003;56: 605–609. doi: 10.1016/s0895-4356(03)00083-0 [DOI] [PubMed] [Google Scholar]
  • 26.Jefferson L, Fairhurst C, Brealey S, Coleman E, Cook L, Hewitt C, et al. Remote or on-site visits were feasible for the initial setup meetings with hospitals in a multicenter surgical trial: an embedded randomized trial. J Clin Epidemiol. 2018;100: 13–21. doi: 10.1016/j.jclinepi.2018.04.011 [DOI] [PubMed] [Google Scholar]
  • 27.Watson, Cook, Hudson, Kilonzo. Use of monetary incentives to boost participant questionnaire response rates in the eTHoS study: the ‘to incentivise or not to incentivise’studies. excisional surgery for …. Available: https://www.ncbi.nlm.nih.gov/books/NBK465005/
  • 28.Mitchell AS, Cook L, Dean A, Fairhurst C, Northgraves M, Torgerson DJ, et al. An embedded randomised controlled retention trial of personalised text messages compared to non-personalised text messages in an orthopaedic setting. F1000Res. 2020;9: 591. doi: 10.12688/f1000research.24244.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mitchell AS, Cook L, Dean A, Fairhurst C, Northgraves M, Torgerson DJ, et al. Using pens as an incentive for questionnaire return in an orthopaedic trial: an embedded randomised controlled retention trial. F1000Res. 2020;9: 321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Partha Sarathy P, Kottam L, Parker A, Brealey S, Coleman E, Keding A, et al. Timing of electronic reminders did not improve trial participant questionnaire response: a randomized trial and meta-analyses. J Clin Epidemiol. 2020;122: 70–77. doi: 10.1016/j.jclinepi.2020.03.001 [DOI] [PubMed] [Google Scholar]
  • 31.Renfroe EG, Heywood G, Foreman L, Schron E, Powell J, Baessler C, et al. The end-of-study patient survey: methods influencing response rate in the AVID Trial. Control Clin Trials. 2002;23: 521–533. doi: 10.1016/s0197-2456(02)00225-8 [DOI] [PubMed] [Google Scholar]
  • 32.Eccles BK, Cross W, Rosario DJ, Doble A, Parker C, Logue J, et al. SABRE 1 (Surgery Against Brachytherapy—a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer. BJU Int. 2013;112: 330–337. doi: 10.1111/bju.12127 [DOI] [PubMed] [Google Scholar]
  • 33.Parker A, Arundel C, Mills N, Rooshenas L, Jepson M, Donovan JL, et al. Staff training to improve participant recruitment into surgical randomised controlled trials: A feasibility study within a trial (SWAT) across four host trials simultaneously. Research Methods in Medicine & Health Sciences. 2022; 26320843221106950. [Google Scholar]
  • 34.Agni NR, Fairhurst C, McDaid C, Reed MR, Torgerson DJ. EnTraP: A factorial randomised controlled trial embedded within world hip trauma evaluation eight COPAL investigating the effect of an enhanced trainee principal investigator package and digital nudge on recruitment rates. Research Methods in Medicine & Health Sciences. 2022;3: 33–41. [Google Scholar]
  • 35.Coleman E, Arundel C, Clark L, Doherty L, Gillies K, Hewitt C, et al. Bah humbug! Association between sending Christmas cards to trial participants and trial retention: randomised study within a trial conducted simultaneously across eight host trials. BMJ. 2021;375: e067742. doi: 10.1136/bmj-2021-067742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Starr K, McRae D, Gillies K, Cooper C, Wolfe A. SWAT 89: Including a theoretically informed leaflet in a participant takehome pack of questionnaires to increase response rate. 2019. Available: https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,911406,en.pdf [Google Scholar]
  • 37.McCaffery J, Arundel C, Chetter I, Fairhurst C, Joshi K, Mott A, et al. SWAT 116: Impact on recruitment of adding an Infographic to a Patient Information Leaflet. 2019. Available: https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,959361,en.pdf [Google Scholar]
  • 38.Arundel C, Chetter I, Fairhurst C, Joshi K, McCaffery J, Mott A, et al. SWAT 119: Effects on retention of giving trial participants a thank you card following each study visit. 2019. Available: https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,959362,en.pdf [Google Scholar]
  • 39.Reed M, Randall J. SWAT 83: Postal vs telephone follow-up. 2018. Available: https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,864305,en.pdf [Google Scholar]
  • 40.Montgomery A, Brittain C, Khan S, Lewis M, Tan W, Goyal A, et al. Addition of a pictorial aid to the patient information leaflet to improve recruitment in a randomised trial. 2019. Available: https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,927252,en.pdf [Google Scholar]
  • 41.Donovan JL, Jepson M, Rooshenas L, Paramasivan S, Mills N, Elliott D, et al. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment. Trials. 2022;23: 258. doi: 10.1186/s13063-022-06187-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Burke JR, Glasbey J, Nepogodiev D, Drake T, Blencowe N, Rooshenas L, et al. Improving communication in recruitment consultations for randomised controlled trials. Bull R Coll Surg Engl. 2017;99: 260–263. [Google Scholar]
  • 43.Dawson S, Banister K, Biggs K, Cotton S, Devane D, Gardner H, et al. Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice. Trials. 2022;23: 672. doi: 10.1186/s13063-022-06553-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, et al. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials. 2020;21: 694. doi: 10.1186/s13063-020-04613-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Treweek S. Evidence pack–Retention: adding a pen (ID Ret3). In: Trial Forge [Internet]. 7 May 2020. [cited 19 Aug 2022]. Available: https://www.trialforge.org/resource/evidence-pack-retention-adding-a-pen-ret3/ [Google Scholar]
  • 46.York Trials Unit. 2022. [Google Scholar]

Decision Letter 0

Elisa Ambrosi

1 Feb 2023

PONE-D-22-32540Recruitment and retention strategies in surgical and wound care trials: a systematic reviewPLOS ONE

Dear Dr. Arundel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Elisa Ambrosi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

3. We note that this manuscript is a systematic review or meta-analysis; our author guidelines therefore require that you use PRISMA guidance to help improve reporting quality of this type of study. Please upload copies of the completed PRISMA checklist as Supporting Information with a file name “PRISMA checklist”."

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article is well written and addresses a substantial problem for researchers: patient enrolment and retention.

The abstract is well written.

The introduction introduces appropriately the reader to the topic. However, it doesn't appear clear why the authors decided to investigate both surgical trials and wound trials. Please argument why the two populations can be analysed together.

Discussion "findings were not unsurprising; additional

visits to sites and recruitment by a urologist rather than a nurse were more expensive.

Retention at subsequent time points was not assessed in any of the included retention

SWATs." In this paragraph I would expect the authors to justify why they find the results not unsurprising. Please, consider also revise the terms "not unsurprising2, which may be difficult to understand for someone not speaking in English as first language.

Moreover, it would be nice to comment the replicability of the results in the discussion in relation to the limited part of the population described (white, males).

Reviewer #2: Thank you for the opportunity to review this manuscript which presents the findings from a systematic review of interventions to improve recruitment and/or retention in clinical trials set within surgery or wound care. I have some specific points for consideration which are listed below.

Abstract

• For both the abstract and the introduction I think the rationale for the need for this review could be clearer. As written it states that recruitment and retention are an ongoing issue for trials. There are lots of operations and people living with chronic wounds and therefore assessment of this context is important. I would argue there needs to be a more direct link between recruitment and retention and surgical and wound care trials, rather than high numbers in clinical care. For example, do they routinely under-recruit/retain – what is the problem that this review is addressing? This needs strengthened.

• Within abstract methods section helpful to state ‘within a surgical or wound based host randomised controlled trial’ so as to be consistent with terminology throughout re host trials – which will help readers.

• There isn’t any information on the analysis methods used in the methods section.

• Results section states 11 studies were included but in the main text it states 12 and 12 studies are included in the tables.

Introduction

• Within the opening sentences there are several uses of ‘their’. Sometimes it isn’t clear which ‘their’ the author is referring to. Maybe clearer to be more specific e.g sentence 2 – The validity and reliability of RCTs is highly dependent on recruiting and retaining….’

• Within introduction sometimes the ‘interventions’ are referred to as methods sometimes strategies – would be helpful to be consistent.

• Point re rationale made above for abstract also needs addressed here.

• I didn’t understand the second section of the last sentence of the second paragraph.

• Last sentence of paragraph 3. The point being made re evidence from quasi or non-randomised designs – is this in relation to the design of the recruitment and retention trial or the host trial? I didn’t then understand how this links to the point re ‘real’ trials. Isnt that more that some trials included in the Cochrane recruitment review were hypothetical?

Methods

• Sentence that states studies were not eligible if they were hypothetical needs clarification. If the host parent trials was hypothetical? The SWAT? Both?

• Were any other types of studies excluded?

• Would be helpful to state how the outcomes of recruitment and retention were defined.

• Was unit of randomisation collected as a SWAT characteristic?

• In Synthesis section it states a flowchart ‘will be presented’ – needs changed to ‘are’

Results

• Reports that 12 studies were included – ensure address mismatch with abstract

• When stating studies use a direct approach – can you give an i.e. to hep the reader.

• Likewise when stating postal follow up – maybe include postal questionnaire follow up.

• The results state that one intervention (patient information video decision aid) was evaluated in ‘multiple’ studies. It was evaluated in 2 studies – why weren’t these studies considered for meta-analysis?

• Risk of bias – states 11 studies were included.

• Recruitment section

o second para opens stating 4 of the 6 SWATs – but weren’t there 7? 4 on consent info, 1 on study set up and 2 on training.

o I think it would be helpful to provide more information on ‘consent information’ interventions. This could mean the content and/or the mode pf delivery of information has been modified. Would be helpful to provide further details – could consider using similar categories to the Cochrane review.

o Para 7 – should be ‘were’ not ‘was’ identified.

• Retention section

o Last sentence of first para – were these host trials that were factorial?

o 2nd para last sentence – I wasn’t clear why the authors report the SWATs focused on provision of consent information and study set up – isn’t that relevant for the recruitment interventions not retention.

• Could the authors comment on why the following paper wasn’t included as some of the included trials are surgical–

o Coleman E, Arundel C, Clark L, Doherty L, Gillies K, Hewitt C et al. Bah humbug! Association between sending Christmas cards to trial participants and trial retention: randomised study within a trial conducted simultaneously across eight host trials BMJ 2021; 375 :e067742

Discussion

• Discussion needs edited base don ‘consent information; interventions description being expanded

• 2nd para last sentence – reads that replications are required due to heterogeneity of interventions. But replications are also required due to small sample sizes which means that individual studies don’t provide high quality, reliable, evidence. This point needs to be covered in discussion.

• Would be helpful to also cover priorities for recruitment and retention intervention testing as stated in Cochrane reviews.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr Katie Gillies

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jul 20;18(7):e0288028. doi: 10.1371/journal.pone.0288028.r002

Author response to Decision Letter 0


6 Mar 2023

Reviewer 1

The introduction introduces appropriately the reader to the topic. However, it doesn't appear clear why the authors decided to investigate both surgical trials and wound trials. Please argument why the two populations can be analysed together.

We are pleased that the introduction provided a helpful summary of the topic but apologise it was not clear why the populations were combined. We have updated the introduction section to reflect that surgery often leads to wounds and therefore the populations are likely to be similar, hence the grouping here.

Discussion "findings were not unsurprising; additional visits to sites and recruitment by a urologist rather than a nurse were more expensive. Retention at subsequent time points was not assessed in any of the included retention SWATs."

In this paragraph I would expect the authors to justify why they find the results not unsurprising. Please, consider also revise the terms "not unsurprising”, which may be difficult to understand for someone not speaking in English as first language.

We apologise that this wording was ambiguous. The Discussion has been updated accordingly to reflect the results were expected given the resource implications associated with the expensive interventions.

Moreover, it would be nice to comment the replicability of the results in the discussion in relation to the limited part of the population described (white, males).

This suggestion to update the discussion to reflect the EDI of participants has been actioned accordingly to reflect the population is predominantly older patients, largely white ethnicity.

Reviewer 2

For both the abstract and the introduction I think the rationale for the need for this review could be clearer. As written it states that recruitment and retention are an ongoing issue for trials. There are lots of operations and people living with chronic wounds and therefore assessment of this context is important. I would argue there needs to be a more direct link between recruitment and retention and surgical and wound care trials, rather than high numbers in clinical care. For example, do they routinely under-recruit/retain – what is the problem that this review is addressing? This needs strengthened.

We are sorry that the rationale for the review was not clear. We have updated the abstract and introduction to make clear the difficulties with recruitment/retention in surgical trials and given that surgery often leads to wounds and therefore the populations are likely to be similar, hence why these were grouped together.

Within abstract methods section helpful to state ‘within a surgical or wound based host randomised controlled trial’ so as to be consistent with terminology throughout re host trials – which will help readers.

We thank the reviewer for this note re consistency and have updated the Abstract – Methods accordingly.

There isn’t any information on the analysis methods used in the methods section.

We thank the reviewer for noting this missingness. The Abstract – Methods has been updated to reflect the analysis methods used.

Results section states 11 studies were included but in the main text it states 12 and 12 studies are included in the tables.

We apologise for the inaccuracy of the reporting here. This was clearly missed when we updated the manuscript with an updated search. The Abstract – Results section has been updated accordingly.

Within the opening sentences there are several uses of ‘their’. Sometimes it isn’t clear which ‘their’ the author is referring to. Maybe clearer to be more specific e.g sentence 2 – The validity and reliability of RCTs is highly dependent on recruiting and retaining….’

We appreciate that the use of their may have caused ambiguity in the initial sentences of the Introduction and have amended this accordingly for clarity.

Within introduction sometimes the ‘interventions’ are referred to as methods sometimes strategies – would be helpful to be consistent.

We thank the reviewer for their suggestion here – the manuscript has been reviewed and updated throughout for consistency

Point re rationale made above for abstract also needs addressed here. As above we have updated the abstract and introduction to better reflect the rationale.

I didn’t understand the second section of the last sentence of the second paragraph.

We apologise this point was not clear. On review this duplicates information provided in Paragraph 3 and so has been removed

Last sentence of paragraph 3. The point being made re evidence from quasi or non-randomised designs – is this in relation to the design of the recruitment and retention trial or the host trial? I didn’t then understand how this links to the point re ‘real’ trials. Isnt that more that some trials included in the Cochrane recruitment review were hypothetical? We have made clearer that the quasi and non randomised designs are relating to the SWAT and have also made reference to hypothetical designs as suggested. We have removed the reference to ‘real’ trials for avoidance of confusion

Sentence that states studies were not eligible if they were hypothetical needs clarification. If the host parent trials was hypothetical? The SWAT? Both?

The Methods – Eligibility Criteria section has been clarified as requested.

Were any other types of studies excluded?

The inclusion criteria note studies as eligible for inclusion if the host trial and SWAT were randomised. We have amended the exclusion criteria to make clear non randomised or quasi randomised designs were not eligible to make this clearer.

Would be helpful to state how the outcomes of recruitment and

retention were defined.

As requested definitions of recruitment and retention have been added to the Methods – Outcome data section

Was unit of randomisation collected as a SWAT characteristic?

We did not separately extract unit of randomisation but this was collected as part of the number of participants recruited to each arm, whereby this was noted as the number of sites for relevant studies. We have updated the Methods – Data Items to include this.

In Synthesis section it states a flowchart ‘will be presented’ – needs changed to ‘are’

We apologise for the oversight in tense here. This has been updated accordingly.

Reports that 12 studies were included – ensure address mismatch with abstract

We apologise for the inaccuracy of the reporting here. This was clearly missed when we updated the manuscript with an updated search. The Abstract – Results section has been updated accordingly.

When stating studies use a direct approach – can you give an i.e. to hep the reader.

This is a useful addition and we have added as suggested to the Results – Study Characteristics section.

Likewise when stating postal follow up – maybe include postal questionnaire follow up.

This is a useful addition and we have added as suggested to the Results – Study Characteristics section.

The results state that one intervention (patient information video decision aid) was evaluated in ‘multiple’ studies. It was evaluated in 2 studies – why weren’t these studies considered for meta-analysis?

The authors have re-reviewed this decision and agree that the two interventions were too heterogeneous to warrant combining via meta analysis. We have updated the results section to remove any ambiguity here.

Risk of bias – states 11 studies were included We apologise for the inaccuracy of the reporting here. This was clearly missed when we updated the manuscript with an updated search. The Results – Risk of Bias section has been updated accordingly. In undertaking this we noted that the assessment for Parker et al was inadvertently missed from the reporting – this has been added accordingly.

Recruitment section

o second para opens stating 4 of the 6 SWATs – but weren’t there 7? 4 on consent info, 1 on study set up and 2 on training.

o I think it would be helpful to provide more information on ‘consent information’ interventions. This could mean the content and/or the mode pf delivery of information has been modified. Would be helpful to provide further details – could consider using similar categories to the Cochrane review.

o Para 7 – should be ‘were’ not ‘was’ identified. We apologise for the inaccuracy of the reporting here. This was clearly missed when we updated the manuscript with an updated search. The Results – Recruitment section has been updated accordingly.

This is a helpful suggestion and we have updated the manuscript to make clear the types of consent information interventions.

We apologise for the oversight in tense here. This has been updated accordingly.

Retention section

o Last sentence of first para – were these host trials that were factorial?

o 2nd para last sentence – I wasn’t clear why the authors report the SWATs focused on provision of consent information and study set up – isn’t that relevant for the recruitment interventions not retention.

It was the SWATs which were factorial – we have updated the Results – Retention section for clarity

We thank the reviewer for spotting this oversight- you are correct the provision of consent information and set up should not be detailed here. We have revised this section to report the retention interventions correctly.

Could the authors comment on why the following paper wasn’t included as some of the included trials are surgical–

o Coleman E, Arundel C, Clark L, Doherty L, Gillies K, Hewitt C et al. Bah humbug! Association between sending Christmas cards to trial participants and trial retention: randomised study within a trial conducted simultaneously across eight host trials BMJ 2021; 375 :e067742

At the time of initial search this publication was not available so not included and it appears the subsequent search did not pick up this publication either, possibly due to the timing of indexing. We acknowledge that this should have been included however and so have added this in accordingly.

Discussion needs edited based on ‘consent information; interventions description being expanded

We have updated the Discussion section to reflect the types of consent information interventions included.

2nd para last sentence – reads that replications are required due to heterogeneity of interventions. But replications are also required due to small sample sizes which means that individual studies don’t provide high quality, reliable, evidence. This point needs to be covered in discussion

This is an excellent point – we have updated this section of the Discussion to reflect the impacts of the sample sizes here.

Would be helpful to also cover priorities for recruitment and retention intervention testing as stated in Cochrane reviews. This is a helpful suggestion and one which has now been reflected on within the Discussion section

Attachment

Submitted filename: Response to Reviewers 03.02.2022_.docx

Decision Letter 1

Elisa Ambrosi

26 Apr 2023

PONE-D-22-32540R1Recruitment and retention interventions in surgical and wound care trials: a systematic reviewPLOS ONE

Dear Dr. Arundel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 10 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Elisa Ambrosi

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract: the introduction is not clear and it doesn't introduce properly the two populations under scrutiny and why retention is a problem. In the abstract the authors state there are 7 articles included for recruitment, but then they say "four out of the SIX".

Introduction: as the previous reviewer undelined, the authors didn't justify clearly why surgical and wound care trials against all other trials, need to be addressed in terms of retention strategies, there needs to be a more direct link between recruitment and retention and surgical and wound care trials, rather than high numbers in clinical care. Moreover, in the comments to the authors, the authors declare that they included 12 articles, but in reality in the manuscript there are 13 articles.

Analysis: if there are 13 RCTs, it should be justified why the authors talk about 14 interventions.

Results ". A further record was subsequently identified for inclusion given 62.5% of included studies were surgical or wound care related". This sentence is not clear to me: Why this further record has not been included among the 13? why is it relevant to state that 62.5% of the studies where surgical or wound care related?

Page 24: please consider changing "results where not unsurprising". Discussion: in the last paragraph the authors state that "Half of the studies included used clinic follow-up either alone or in conjunction with remote

follow-up. It would be interesting to discuss what are the forms of remote follow up. A recent systematic review by Mette Brøgger-Mikkelsen et al (2020) hightlighted that Online recruitment was both superior in regard to time efficiency and cost-effectiveness compared with offline recruitment and this could be an effective strategy to improve the low attendance at face-to-face visits in trials.

Moreover, the systematic review cited by the authors in the last paragraph needs to be correctly cited.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr Katie Gillies

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jul 20;18(7):e0288028. doi: 10.1371/journal.pone.0288028.r004

Author response to Decision Letter 1


15 May 2023

Abstract: the introduction is not clear and it doesn't introduce properly the two populations under scrutiny and why retention is a problem.

We apologise that the introduction was unclear as to the two populations under scrutiny. We have sought to revise the introduction section to make this clearer whilst remaining within the confines of the journal word count for the abstract.

In the abstract the authors state there are 7 articles included for recruitment, but then they say "four out of the SIX". We apologise for the oversight here when revising this manuscript. This has been corrected accordingly.

Introduction: as the previous reviewer undelined, the authors didn't justify clearly why surgical and wound care trials against all other trials, need to be addressed in terms of retention strategies, there needs to be a more direct link between recruitment and retention and surgical and wound care trials, rather than high numbers in clinical care.

Moreover, in the comments to the authors, the authors declare that they included 12 articles, but in reality in the manuscript there are 13 articles.

We are sorry that the amendments made to the introduction did not satisfactorily deal with the previous reviewer comments. We have made further revisions to the introduction to note the difficulties in both recruitment and retention in these trial types.

We have thoroughly checked the manuscript to ensure that it is clear that 13 articles in total were included in the review.

Analysis: if there are 13 RCTs, it should be justified why the authors talk about 14 interventions.

We apologise for the inaccuracy here. The analysis section has been amended to remove details of the number of interventions for avoidance of any confusion.

A further record was subsequently identified for inclusion given 62.5% of included studies were surgical or wound care related". This sentence is not clear to me: Why this further record has not been included among the 13? why is it relevant to state that 62.5% of the studies where surgical or wound care related?

We apologise for the oversight here when revising the manuscript. The original number of studies included should have been reported as 12, with the additional record increasing this to 13. This has been updated accordingly for clarity.

We suggest it is relevant to report the proportion of surgical/wound care studies in the final included record, given this is a simultaneous SWAT (i.e., conducted in multiple studies at the same time) and not all the studies included would meet the inclusion criteria for this review.

Page 24: please consider changing "results where not unsurprising".

We thank the reviewer for this comment. We have re reviewed the manuscript and amended this sentence in relation to the cost effectiveness of recruitment strategies.

Discussion: in the last paragraph the authors state that "Half of the studies included used clinic follow-up either alone or in conjunction with remote follow-up. It would be interesting to discuss what are the forms of remote follow up. A recent systematic review by Mette Brøgger-Mikkelsen et al (2020) hightlighted that Online recruitment was both superior in regard to time efficiency and cost-effectiveness compared with offline recruitment and this could be an effective strategy to improve the low attendance at face-to-face visits in trials.

Moreover, the systematic review cited by the authors in the last paragraph needs to be correctly cited.

We have added clarification to this sentence to reflect that the remote follow up methods reported were postal. We thank the reviewer for flagging the review by Mette Brogger Mikkelsen et al but have not commented further on this given neither online recruitment nor follow up methods were used by any of the included trials.

We apologise for the incorrect placing of this citation. This has been corrected accordingly.

Attachment

Submitted filename: Response to Reviewers 12.05.2023.docx

Decision Letter 2

Elisa Ambrosi

19 Jun 2023

Recruitment and retention interventions in surgical and wound care trials: a systematic review

PONE-D-22-32540R2

Dear Dr. Arundel,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Elisa Ambrosi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all previous concerns. The number of the articles has been fixed and the additional comments revised.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Katie Gillies

**********

Acceptance letter

Elisa Ambrosi

12 Jul 2023

PONE-D-22-32540R2

Recruitment and retention interventions in surgical and wound care trials: a systematic review

Dear Dr. Arundel:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Elisa Ambrosi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    S2 File

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers 03.02.2022_.docx

    Attachment

    Submitted filename: Response to Reviewers 12.05.2023.docx

    Data Availability Statement

    Datasets and associated documentation used in this study will be available in the FigShare database https://figshare.com/ 10.6084/m9.figshare.23580270.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES